🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elise F. Nassif

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-3794-6759
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma”.

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z
N/A
0.612DataRank · unranked
58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.10.008
N/A
0.300DataRank · unranked
4 citations

Bryan Fellman, Alejandra Flores Legarreta, Larissa A. Meyer, Nicole D. Fleming, Ravin Ratan +4 more

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

Frontiers in Immunology(2025)10.3389/fimmu.2025.1567736
N/A
0.269DataRank · unranked
5 citations

Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis R. Ingram, Khalida Wani +21 more

Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11511
N/A
0.208DataRank · unranked
3 citations

Rossana Lazcano Segura, Ahsan Farooqi, Davis R. Ingram, Khalida Wani, Yiming Cai +13 more

ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.23.689992
N/A
0DataRank · unranked
0 citations

Anand K. Singh, Yingda Jiang, Zheng Zhao, Davis R. Ingram, Khalida Wani +28 more

Targeting the Molecular and Immunologic Features of Leiomyosarcoma

Cancers(2023)10.3390/cancers15072099
N/A
0DataRank · unranked
27 citations

Raymond Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland +2 more

Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2–mutant tumors: Bridging science with the clinic

Cancer(2025)10.1002/cncr.35890
N/A
0DataRank · unranked
0 citations

Milind Javle, Timothy A. Yap, Elise F. Nassif

Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases

Annals of Surgical Oncology(2022)10.1245/s10434-022-11803-x
N/A
0DataRank · unranked
11 citations

Brandon Cope, Derek J. Erstad, Yi‐Ju Chiang, Elise F. Nassif, Christopher P. Scally +6 more